Editorial: Cardiac metabolic state and brugada syndrome: A link revealed

Circulation Research

Volumn 105, Issue 8, 2009, Pages 721-723

  Chahine, Mohamed ^a  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Brugada syndrome; Cardiac arrhythmias; NADH; Nav1.5; SCN5A

Indexed keywords

BRUGADA SYNDROME; EDITORIAL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SUDDEN DEATH; ANIMAL; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART MUSCLE; HEART VENTRICLE TACHYCARDIA; HUMAN; METABOLISM; MOUSE; MUTATION; NOTE; OXIDATION REDUCTION REACTION; RAT;

ANTINEOPLASTIC AGENT; BENZOPHENANTHRIDINE DERIVATIVE; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GPD1 L PROTEIN, HUMAN; GPD1-L PROTEIN, HUMAN; MUSCLE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN KINASE C; SCN5A PROTEIN, HUMAN; SODIUM; SODIUM CHANNEL; SUPEROXIDE DISMUTASE; VOLTAGE GATED NA+ CHANNEL NA(V)1.5A; VOLTAGE-GATED NA+ CHANNEL NA(V)1.5A;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOPHENANTHRIDINES; BRUGADA SYNDROME; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; ENZYME INHIBITORS; GLYCEROLPHOSPHATE DEHYDROGENASE; HUMANS; MICE; MUSCLE PROTEINS; MUTATION; MYOCARDIUM; NAD; OXIDATION-REDUCTION; PROTEIN KINASE C; RATS; SODIUM; SODIUM CHANNELS; SUPEROXIDE DISMUTASE; TACHYCARDIA, VENTRICULAR;

EID: 70350133633     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.208405     Document Type: Editorial

References (17)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391-1396.
2. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupa-sawadikul S, Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96: 2595-2600.
3. Nademanee K. Sudden unexplained death syndrome in Southeast Asia. Am J Cardiol. 1997;79:10-11.
4. Wilde AAM, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RNW, Kass RS, Nademanee K, Priori SG, Towbin JA. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514-2519. (Pubitemid 35278811)
5. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S, Viswanathan PC, Pfahnl AE, Shang LL, Madhusudanan M, Baty CJ, Lagana S, Aleong R, Gutmann R, Ackerman MJ, McNamara DM, Weiss R, Dudley SC Jr. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation. 2007;116:2260-2268.
6. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Ober-heiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115: 442-449.
7. Cordeiro JM, Marieb M, Pfeiffer R, Calloe K, Burashnikov E, Antzelevitch C. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J Mol Cell Cardiol. 2009;46:695-703.
8. Verkerk AO, Wilders R, Schulze-Bahr E, Beekman L, Bhuiyan ZA, Bertrand J, Eckardt L, Lin D, Borggrefe M, Breithardt G, Mannens MM, Tan HL, Wilde AA, Bezzina CR. Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. Cardiovasc Res. 2005;68:441-453.
9. Koopmann TT, Beekman L, Alders M, Meregalli PG, Mannens MM, Moorman AF, Wilde AA, Bezzina CR. Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort. Heart Rhythm. 2007;4:752-755.
10. Makiyama T, Akao M, Haruna Y, Tsuji K, Doi T, Ohno S, Nishio Y, Kita T, Horie M. Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in Japanese patients with Brugada syndrome. Circ J. 2008;72:1705-1706.
11. Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, Angelilli A, Villanueva F, McNamara DM, London B. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation. 2002;105:707-713.
12. Antzelevitch C. Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesis. Ann Med. 2004;36 Suppl 1:5-14.
13. Van Norstrand DW, Valdivia CR, Tester DJ, Ueda K, London B, Mak-ielski JC, Ackerman MJ. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation. 2007;116: 2253-2259.
14. Liu M, Sanyal S, Gao G, Gurung IS, Zhu X, Gaconnet G, Kerchner LJ, Shang LL, Huang CL-H, Grace A, London B, Dudley SC. Cardiac Na+ current regulation by pyridine nucleotides. Circ Res. 2009;105:737-745.
15. Murray KT, Hu NN, Daw JR, Shin HG, Watson MT, Mashburn AB, George AL Jr. Functional effects of protein kinase C activation on the human cardiac Na+ channel. Circ Res. 1997;80:370-376.
16. Xiao GQ, Qu Y, Sun ZQ, Mochly-Rosen D, Boutjdir M. Evidence for functional role of ePKC isozyme in the regulation of cardiac Na+ channels. Am J Physiol. 2001;281:C1477-C1486.
17. Papadatos GA, Wallerstein PMR, Head CEG, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AEO, Huang CLH, Vandenberg JI, Colledge WH, Grace AA. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci USA. 2002;99:6210-6215.